化合物HDAC-IN-40 T60082
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 2463198-51-6 | ¥395.00 | 询底价 |
5 mg | 2463198-51-6 | ¥947.00 | 询底价 |
50 mg | 2463198-51-6 | ¥5,360.00 | 询底价 |
100 mg | 2463198-51-6 | ¥7,530.00 | 询底价 |
10 mg | 2463198-51-6 | ¥1,660.00 | 询底价 |
25 mg | 2463198-51-6 | ¥3,660.00 | 询底价 |
Product Introduction
Bioactivity
英文名: HDAC-IN-40
描述: HDAC-IN-40 是一种有效的基于烷氧基酰胺的 HDAC 抑制剂,对 HDAC2 和 HDAC6 的 Ki 分别为 60 nM 和 30 nM。HDAC-IN-40 具有抗肿瘤作用。
体外活性: HDAC-IN-40 shows antiproliferative activity against the cell line A2780 and Cal27 with IC50 values of 0.89 µM and 0.72 µM, respectively. HDAC-IN-40 induces accumulation of acetyl α-tubulin in Cal27 and Cal27CisR. HDAC-IN-40 enhances the Cisplatin-induced cytotoxicity via caspase-3/7 activation[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 200 mg/mL (612.9 mM)
关键字: HDACIN40 | HDAC IN 40 | HDAC-IN-40
相关产品: NKL 22 | Rac-Belinostat | ACY-957 | CAY10603 | SR-4370 | HDAC8-IN-20a | CHDI-390576 | EDO-S101 | 4-Phenylbutyric acid | BRD 4354
相关库: NF-κB Signaling Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Epigenetics Compound Library | Anti-Cancer Active Compound Library | DNA Damage & Repair Compound Library | Anti-Pancreatic Cancer Compound Library | Histone Modification Compound Library | Bioactive Compound Library | Chromatin Modification Compound Library
化合物HDAC-IN-40 T60082信息由TargetMol中国为您提供,如您想了解更多关于化合物HDAC-IN-40 T60082报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途